Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
Sebastián Riquelme is one of the pioneers in the growing field of immunometabolism, investigating how the processes that turn food into energy impact the outcome of infectious diseases.
The coming COVID boosters aren't the only vaccines adults should consider. Now's a good time for people over 18 to make sure they're up to date with flu, tetanus, and other routine vaccines.
When the virus arrived in New York City, VP&S clinicians were redeployed to areas in need, researchers pivoted to COVID research, and students graduated early to help “bend the curve.”
Front-line physicians, nurses, and staff at Columbia University Irving Medical Center have begun receiving the initial doses of the first COVID vaccines.
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Columbia’s Evelyn Berger-Jenkins, MD, has co-authored new recommendations to help pediatricians address emotional and behavioral health issues in children during the COVID-19 pandemic.
On World AIDS Day, David Ho, MD, received the National Leadership Recognition Award from the National AIDS Memorial and spoke at a virtual event about the impacts of HIV/AIDS and COVID-19.
This year’s Crown Awards video celebrated our front line heroes—physicians, researchers, staff, students, and trainees—who have responded so valiantly to the COVID-19 pandemic.
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
Compared with adults, children produce a very different antibody response after infection with the new coronavirus, SARS-CoV-2, suggesting they clear the virus easily.